UBS Group’s Alignment Healthcare ALHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5M | Buy |
824,871
+341,039
| +70% | +$4.77M | ﹤0.01% | 2299 |
|
|
2025
Q1 | $9.01M | Buy |
483,832
+248,384
| +105% | +$4.62M | ﹤0.01% | 2447 |
|
|
2024
Q4 | $2.65M | Buy |
235,448
+160,268
| +213% | +$1.8M | ﹤0.01% | 3487 |
|
|
2024
Q3 | $889K | Buy |
75,180
+25,663
| +52% | +$303K | ﹤0.01% | 3683 |
|
|
2024
Q2 | $387K | Sell |
49,517
-37,685
| -43% | -$295K | ﹤0.01% | 4103 |
|
|
2024
Q1 | $433K | Buy |
87,202
+85,031
| +3,917% | +$422K | ﹤0.01% | 4207 |
|
|
2023
Q4 | $18.7K | Buy |
2,171
+2,111
| +3,518% | +$18.2K | ﹤0.01% | 5945 |
|
|
2023
Q3 | $416 | Sell |
60
-69,530
| -100% | -$482K | ﹤0.01% | 7362 |
|
|
2023
Q2 | $400K | Buy |
69,590
+36,615
| +111% | +$211K | ﹤0.01% | 4003 |
|
|
2023
Q1 | $210K | Sell |
32,975
-25,129
| -43% | -$160K | ﹤0.01% | 4317 |
|
|
2022
Q4 | $683K | Buy |
58,104
+53,645
| +1,203% | +$631K | ﹤0.01% | 3442 |
|
|
2022
Q3 | $53K | Buy |
4,459
+3,811
| +588% | +$45.3K | ﹤0.01% | 5229 |
|
|
2022
Q2 | $8K | Sell |
648
-6,736
| -91% | -$83.2K | ﹤0.01% | 7238 |
|
|
2022
Q1 | $83K | Sell |
7,384
-21,192
| -74% | -$238K | ﹤0.01% | 5046 |
|
|
2021
Q4 | $401K | Buy |
28,576
+26,842
| +1,548% | +$377K | ﹤0.01% | 4147 |
|
|
2021
Q3 | $28K | Buy |
1,734
+1,059
| +157% | +$17.1K | ﹤0.01% | 5684 |
|
|
2021
Q2 | $16K | Buy |
675
+365
| +118% | +$8.65K | ﹤0.01% | 6463 |
|
|
2021
Q1 | $7K | Buy |
+310
| New | +$7K | ﹤0.01% | 7103 |
|